Estramustine phosphate sodium (Estracyt)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Estramustine phosphate sodium (Estracyt), covering 2014-05-22 to 2014-05-22. Get the full timeline:
Most recent: Clinical Trial Update: Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [Phase 2]